Back to Authors

Kadom, Nadja

https://orcid.org/0000-0002-1591-9357

Mayo Clinic

Emory University

Citations 2

Imaging of pediatric spine and spinal cord tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee/ASPNR White Paper
Rogers, Samuel N, Udayasankar, Unni , Lai, Hollie , Kadom, Nadja , Guerin, Julie, Shulkin, Barry L , Pruthi, Sumit , Guérin, J. , Malinzak, Michael D. , Shulkin, Barry L. , Poussaint, Tina Young , Patay, Zoltan J , Bag, Asim Kumar

Pediatric Blood & Cancer | December 23, 2022 | Volume: 70 | Issue: S4 | Pages: No page available

10.1002/pbc.30150 Get It

AbstractChildhood spinal tumors are rare. Tumors can involve the spinal cord, the meninges, bony spine, and the paraspinal tissue. Optimized imaging should be utilized to evaluate tumors arising from specific spinal compartments. This paper provides consensus‐based recommendations for optimized imaging of tumors arising from specific spinal compartments at diagnosis, follow‐up during and after therapy, and response assessment.
Genetic and Clinical Heterogeneity in eIF2B-Related Disorder
Maletkovic, Jelena , Gorospe, J. Rafael, Gordon, Erynn S. , Mintz, Michelle, Hoffman, Eric P. , Alper, Gülay, Singhal, Bhim , Amartino, Hernán , Brown, Candida, Chan, Alicia , Renaud, Deborah L. , Geraghty, Michael T. , Jensen, Lloyd, Şenbil, Nesrin , Kadom, Nadja , Nazarian, Javad , Feng, Yuanjian, Wang, Zuyi, Morizono, Hiroki , Vanderver, Adeline , Schiffmann, Raphael , Lynch, David R. , Harding, Cary O. , Hartka, Thomas , Nazarian, Javad

Journal of Child Neurology | February 8, 2008 | Volume: 23 | Issue: 2 | Pages: 205-215

10.1177/0883073807308705 Get It

Eukaryotic initiation factor 2B (eIF2B)-related disorders are heritable white matter disorders with a variable clinical phenotype (including vanishing white matter disease and ovarioleukodystrophy) and an equally heterogeneous genotype. We report 9 novel mutations in the EIF2B genes in our subject population, increasing the number of known mutations to more than 120. Using homology modeling, we have analyzed the impact of novel mutations on the 5 subunits of the eIF2B protein. Although recurrent mutations have been found at CpG dinucleotides in the EIF2B genes, the high incidence of private or low frequency mutations increases the challenge of providing rapid genetic confirmation of this disorder, and limits the application of EIF2B screening in cases of undiagnosed leukodystrophy.